These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31243901)

  • 1. Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women.
    Chen X; Wei S; Ma H; Jin G; Hu Z; Suping H; Li D; Hang D; Wu X; Li N
    Cancer Med; 2019 Aug; 8(10):4845-4851. PubMed ID: 31243901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Telomere Length in Cervical Exfoliated Cells among Women with High-Risk Human Papillomavirus.
    Al-Awadhi R; Alwehaidah MS; AlRoomy M; Kapila K
    Pathobiology; 2024; 91(3):180-186. PubMed ID: 37913757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women.
    Sun W; Qin X; Zhou J; Xu M; Lyu Z; Li X; Zhang K; Dai M; Li N; Hang D
    BMC Womens Health; 2020 Jul; 20(1):139. PubMed ID: 32615963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection.
    Pańczyszyn A; Boniewska-Bernacka E; Głąb G
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):51-55. PubMed ID: 32039800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere Length, Telomerase Activity, and Vaginal Microbiome in Patients with HPV-Related Precancerous Lesions.
    Boniewska-Bernacka E; Pańczyszyn A; Głąb G; Goc A
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Sasaki Y; Iwanari O; Arakawa I; Moriya T; Mikami Y; Iihara K; Konno R
    Int J Gynecol Cancer; 2017 Mar; 27(3):523-529. PubMed ID: 27997455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
    Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
    Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of human papillomavirus and risk of cervical adenocarcinoma.
    Dahlström LA; Ylitalo N; Sundström K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami HO; Sparén P
    Int J Cancer; 2010 Oct; 127(8):1923-30. PubMed ID: 20473898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt.
    Thabet M; Hemida R; Hasan M; Elshamy M; Elfaraash M; Emam M
    J Exp Ther Oncol; 2014; 10(4):247-53. PubMed ID: 25509977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
    Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
    J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
    Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
    J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.
    Smith EM; Ritchie JM; Summersgill KF; Hoffman HT; Wang DH; Haugen TH; Turek LP
    J Natl Cancer Inst; 2004 Mar; 96(6):449-55. PubMed ID: 15026470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotypes and cervical cancer in northeast Thailand.
    Natphopsuk S; Settheetham-Ishida W; Pientong C; Sinawat S; Yuenyao P; Ishida T; Settheetham D
    Asian Pac J Cancer Prev; 2013; 14(11):6961-4. PubMed ID: 24377633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.